The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Chemotherapeutic safety management system (CSMS) for the safe use of cancer chemotherapy (CTx).
K. Kawada
No relevant relationships to disclose
N. Hamajima
No relevant relationships to disclose
M. Amano
No relevant relationships to disclose
J. Ueda
No relevant relationships to disclose
K. Oji
No relevant relationships to disclose
M. Maeda
No relevant relationships to disclose
T. Kushihara
No relevant relationships to disclose
N. Mukoyama
No relevant relationships to disclose
H. Kushihara
No relevant relationships to disclose
Y. Ikeda
No relevant relationships to disclose
F. Nomura
No relevant relationships to disclose